Mrs. Jessica Dawn Yoder, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1964 Logan Rd, Osceola Mills, PA 16666 Phone: 814-343-2573 |
News Archive
Hastings Center Scholar Erik Parens, PhD, will speak about behavioral genetics to the Presidential Commission for the Study of Bioethical Issues on Monday, February 28. The meeting kicks off the Commission's examination of the ethical and policy issues raised by genetics and neuroscience. Topics will include the use of genetics, neuroscience, and neuroimaging for testing, research, diagnosis, risk identification, and health promotion. Parens was invited to discuss what he considers the most pressing ethical and social issues that behavioral genetics research raises.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase II trial for odanacatib, an investigational cathepsin K (cat-K) inhibitor in development for the treatment of osteoporosis in post-menopausal women.
Heart-healthy diets that reduce calorie intake - regardless of differing proportions of fat, protein, or carbohydrate - can help overweight and obese adults achieve and maintain weight loss, according to a study funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, and published Feb. 26, 2009, in the New England Journal of Medicine.
Tasigna (nilotinib) capsules have been approved with conditions in Canada as a new therapy for patients with CML, in the chronic phase (first phase) of the disease. Patients must be resistant to or intolerant of at least one prior therapy, including (Pr)Gleevec (imatinib mesylate), an established standard of care.
› Verified 2 days ago